Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about Proteasome: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
Proteasome is a biological pathway involved in neurodegeneration research. Key relationships include: activates, regulates, therapeutic target. Associated with ALS, Aging, Als. Connected to 711 entities in the SciDEX knowledge graph.
| Name | Proteasome |
| Key Genes/Proteins | AUTOPHAGY, UBIQUITIN, PARKINSON'S DISEASE, NEURODEGENERATION, CANCER |
| Related Diseases | Neurodegeneration, Als |
| Linked Hypotheses | 1 hypotheses |
Knowledge base pages for this entity
graph TD
Proteasome["Proteasome"] -->|"interacts"| Blood_Brain_Barrier["Blood-Brain Barrier"]
Proteasome["Proteasome"] -->|"interacts"| Ubiquitin_Proteasome["Ubiquitin-Proteasome"]
Proteasome["Proteasome"] -->|"interacts"| Autophagy["Autophagy"]
Proteasome["Proteasome"] -->|"interacts"| Unfolded_Protein_Response["Unfolded Protein Response"]
Proteasome["Proteasome"] -->|"interacts"| Mtor["Mtor"]
Proteasome["Proteasome"] -->|"interacts"| Apoptosis["Apoptosis"]
OCLN["OCLN"] -->|"activates"| Proteasome["Proteasome"]
BECN1["BECN1"] -->|"activates"| Proteasome["Proteasome"]
CLDN5["CLDN5"] -->|"activates"| Proteasome["Proteasome"]
CAV1["CAV1"] -->|"activates"| Proteasome["Proteasome"]
style Proteasome fill:#1b5e20,stroke:#4fc3f7,stroke-width:2px,color:#e0e0e0| Target | Relation | Type | Str |
|---|---|---|---|
| TAU | degrades | protein | 0.85 |
| Dementia | activates | disease | 0.60 |
| Als | activates | disease | 0.60 |
| Stroke | activates | disease | 0.60 |
| Als | inhibits | disease | 0.60 |
| Ischemia | inhibits | disease | 0.60 |
| Aging | degrades | disease | 0.60 |
| Ischemia | associated_with | disease | 0.60 |
| Als | interacts_with | disease | 0.60 |
| Aging | activates | disease | 0.60 |
| Cancer | activates | disease | 0.60 |
| Ferroptosis | degrades | disease | 0.60 |
| Ferroptosis | causes | disease | 0.60 |
| Neurodegeneration | causes | disease | 0.60 |
| Aging | inhibits | disease | 0.60 |
| Alzheimer | inhibits | disease | 0.60 |
| Cancer | therapeutic_target | disease | 0.60 |
| Neurodegeneration | therapeutic_target | disease | 0.60 |
| Als | expressed_in | disease | 0.60 |
| Alzheimer | regulates | disease | 0.60 |
| Als | therapeutic_target | disease | 0.60 |
| Parkinson | therapeutic_target | disease | 0.60 |
| Alzheimer | contributes_to | disease | 0.60 |
| Diabetes | regulates | disease | 0.60 |
| Atherosclerosis | regulates | disease | 0.60 |
| Parkinson | activates | disease | 0.60 |
| Aging | expressed_in | disease | 0.60 |
| Cancer | expressed_in | disease | 0.60 |
| Huntington | transports | disease | 0.60 |
| Parkinson | transports | disease | 0.60 |
| Alzheimer | transports | disease | 0.60 |
| Parkinson | associated_with | disease | 0.60 |
| Neurodegeneration | associated_with | disease | 0.60 |
| Prion Disease | regulates | disease | 0.60 |
| Parkinson | regulates | disease | 0.60 |
| Aging | interacts_with | disease | 0.60 |
| Amyotrophic Lateral Sclerosis | degrades | disease | 0.60 |
| Parkinson | degrades | disease | 0.60 |
| Neurodegeneration | degrades | disease | 0.60 |
| Alzheimer | degrades | disease | 0.60 |
| Fibrosis | therapeutic_target | disease | 0.60 |
| Als | contributes_to | disease | 0.60 |
| Blood-Brain Barrier | interacts_with | pathway | 0.55 |
| Ubiquitin-Proteasome | interacts_with | pathway | 0.55 |
| Autophagy | interacts_with | pathway | 0.55 |
| Unfolded Protein Response | interacts_with | pathway | 0.55 |
| Mtor | interacts_with | pathway | 0.55 |
| Apoptosis | interacts_with | pathway | 0.55 |
| Mitophagy | interacts_with | pathway | 0.55 |
| Ferroptosis | interacts_with | pathway | 0.55 |
| Source | Relation | Type | Str |
|---|---|---|---|
| Als | activates | disease | 1.00 |
| Neurodegeneration | activates | disease | 1.00 |
| Als | inhibits | disease | 1.00 |
| Neurodegeneration | therapeutic_target | disease | 1.00 |
| Als | therapeutic_target | disease | 1.00 |
| Parkinson | therapeutic_target | disease | 1.00 |
| Als | regulates | disease | 1.00 |
| AUTOPHAGY | regulates | gene | 1.00 |
| UBIQUITIN | regulates | gene | 1.00 |
| AUTOPHAGY | activates | gene | 1.00 |
| PARKINSON'S DISEASE | therapeutic_target | gene | 1.00 |
| NEURODEGENERATION | therapeutic_target | gene | 1.00 |
| UBIQUITIN | associated_with | gene | 1.00 |
| UBIQUITIN | inhibits | gene | 1.00 |
| UBIQUITIN | activates | gene | 1.00 |
| CANCER | therapeutic_target | gene | 1.00 |
| UBIQUITIN | therapeutic_target | gene | 1.00 |
| AUTOPHAGY | associated_with | gene | 1.00 |
| NEURODEGENERATION | associated_with | gene | 1.00 |
| NEURODEGENERATION | activates | gene | 1.00 |
| Tumor | therapeutic_target | disease | 1.00 |
| Cancer | therapeutic_target | disease | 1.00 |
| UBIQUITIN | implicated_in | gene | 1.00 |
| PARKINSON | therapeutic_target | gene | 1.00 |
| GENES | activates | gene | 1.00 |
| P62 | activates | gene | 1.00 |
| Aging | therapeutic_target | disease | 1.00 |
| AUTOPHAGY | therapeutic_target | gene | 1.00 |
| P53 | therapeutic_target | gene | 1.00 |
| LYSOSOME | activates | gene | 1.00 |
| Neurodegeneration | associated_with | disease | 1.00 |
| Als | associated_with | disease | 0.95 |
| Aging | activates | disease | 0.90 |
| SQSTM1 | activates | gene | 0.90 |
| APOPTOSIS | therapeutic_target | gene | 0.90 |
| NEURODEGENERATION | regulates | gene | 0.90 |
| CANCER | inhibits | gene | 0.90 |
| NEURODEGENERATION | causes | gene | 0.90 |
| Neurodegeneration | causes | disease | 0.90 |
| Cancer | regulates | disease | 0.85 |
| NEURON | expressed_in | cell_type | 0.85 |
| MTOR | activates | gene | 0.80 |
| ATG | activates | gene | 0.80 |
| Cancer | activates | disease | 0.80 |
| Carcinoma | activates | disease | 0.80 |
| Tumor | activates | disease | 0.80 |
| OVERVIEW | therapeutic_target | gene | 0.80 |
| AKT | therapeutic_target | gene | 0.80 |
| NF-ΚB | inhibits | gene | 0.80 |
| MTOR | therapeutic_target | gene | 0.80 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| Early Proteasome Restoration Therapy | 0.496 | neurodegeneration | Gene expression changes in aging mouse b |
Scientific analyses that reference this entity
No analyses mention this entity
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| Unveiling the Genomic Landscape of Yan Goose (Anser cygnoides): Insights into Po [PMID:41594384] | Qi S, Ai Z, Cai Y, Zhang Y, Zhao W et al | Animals (Basel) | 2026 | 0 |
| NAD+ restores proteostasis through splicing-dependent autophagy. [PMID:41313318] | Ai R, Fang EF | Autophagy | 2026 | 0 |